Middle East Low Molecular Weight Heparin Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Enoxaparin, Dalteparin, Tinzaparin, Fraxiparine, Nadroparin, and Others), Packaging (Multi-Vials and Pre-Filled Syringes), Application (Deep Vein Thrombosis, Acute Coronary Syndrome, Pulmonary Embolism, and Others), End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)

No. of Pages: 216    |    Report Code: BMIRE00027299    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East Low Molecular Weight Heparin Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Middle East Low Molecular Weight Heparin Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Middle East Low Molecular Weight Heparin Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1
  • 5.1.2 High prevalence of blood clot disorders
  • 5.1.3 Increased surgeries requiring anticoagulants
  • 5.1.4 Growing elderly population globally
5.2 Market Opportunities
  • 5.2.1
  • 5.2.2 Expansion in homecare usage
  • 5.2.3 Demand for biosimilar heparins
  • 5.2.4 Increased funding for anticoagulant R&D
5.3 Future Trends
  • 5.3.1
  • 5.3.2 Rise in generic heparin adoption
  • 5.3.3 Focus on subcutaneous formulations
  • 5.3.4 Enhanced safety profile developments
5.4 Impact of Drivers and Restraints

6. Middle East Low Molecular Weight Heparin Market Regional Analysis

6.1 Middle East Low Molecular Weight Heparin Market Overview
6.2 Middle East Low Molecular Weight Heparin Market Revenue 2019-2028 (US$ Million)
6.3 Middle East Low Molecular Weight Heparin Market Forecast Analysis

7. Middle East Low Molecular Weight Heparin Market Analysis – by Product

7.1 Enoxaparin
  • 7.1.1 Overview
  • 7.1.2 Enoxaparin: Middle East Low Molecular Weight Heparin Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Dalteparin
  • 7.2.1 Overview
  • 7.2.2 Dalteparin: Middle East Low Molecular Weight Heparin Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Tinzaparin
  • 7.3.1 Overview
  • 7.3.2 Tinzaparin: Middle East Low Molecular Weight Heparin Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Fraxiparine
  • 7.4.1 Overview
  • 7.4.2 Fraxiparine: Middle East Low Molecular Weight Heparin Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Nadroparin
  • 7.5.1 Overview
  • 7.5.2 Nadroparin: Middle East Low Molecular Weight Heparin Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East Low Molecular Weight Heparin Market Analysis – by Packaging

8.1 Multi-Vials and Pre-Filled Syringes
  • 8.1.1 Overview
  • 8.1.2 Multi-Vials and Pre-Filled Syringes: Middle East Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)

9. Middle East Low Molecular Weight Heparin Market Analysis – by Application

9.1 Deep Vein Thrombosis
  • 9.1.1 Overview
  • 9.1.2 Multi-Vials and Pre-Filled Syringes: Middle East Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Acute Coronary Syndrome
  • 9.2.1 Overview
  • 9.2.2 Multi-Vials and Pre-Filled Syringes: Middle East Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Pulmonary Embolism
  • 9.3.1 Overview
  • 9.3.2 Multi-Vials and Pre-Filled Syringes: Middle East Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)

10. Middle East Low Molecular Weight Heparin Market – Middle East and Africa Analysis

10.1 Middle East and Africa
  • 10.1.1 Middle East Low Molecular Weight Heparin Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 Middle East Low Molecular Weight Heparin Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 South Africa: Middle East Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 South Africa: Middle East Low Molecular Weight Heparin Market Breakdown, by Product
    • 10.1.1.1.2 South Africa: Middle East Low Molecular Weight Heparin Market Breakdown, by Packaging
    • 10.1.1.1.3 South Africa: Middle East Low Molecular Weight Heparin Market Breakdown, by Application
  • 10.1.1.2 Saudi Arabia: Middle East Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Saudi Arabia: Middle East Low Molecular Weight Heparin Market Breakdown, by Product
    • 10.1.1.2.2 Saudi Arabia: Middle East Low Molecular Weight Heparin Market Breakdown, by Packaging
    • 10.1.1.2.3 Saudi Arabia: Middle East Low Molecular Weight Heparin Market Breakdown, by Application
  • 10.1.1.3 UAE: Middle East Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 UAE: Middle East Low Molecular Weight Heparin Market Breakdown, by Product
    • 10.1.1.3.2 UAE: Middle East Low Molecular Weight Heparin Market Breakdown, by Packaging
    • 10.1.1.3.3 UAE: Middle East Low Molecular Weight Heparin Market Breakdown, by Application
  • 10.1.1.4 Rest of Middle East and Africa: Middle East Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Rest of Middle East and Africa: Middle East Low Molecular Weight Heparin Market Breakdown, by Product
    • 10.1.1.4.2 Rest of Middle East and Africa: Middle East Low Molecular Weight Heparin Market Breakdown, by Packaging
    • 10.1.1.4.3 Rest of Middle East and Africa: Middle East Low Molecular Weight Heparin Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Middle East Low Molecular Weight Heparin Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Teva Pharmaceutical Industries Ltd
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Abbott Laboratories
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Novartis AG
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Sanofi
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Pfizer Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 B. Braun SE
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Dr. Reddy's Laboratories
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 LEO Pharma A/S
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Aspen Holdings
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Hikma Pharmaceuticals PLC.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - M Market

  1. Teva Pharmaceutical Industries Ltd
  2. Abbott Laboratories
  3. Novartis AG
  4. Sanofi
  5. Pfizer Inc.
  6. B. Braun SE
  7. Dr. Reddy's Laboratories
  8. LEO Pharma A/S
  9. Aspen Holdings
  10. Hikma Pharmaceuticals PLC.
middle-east-low-molecular-weight-heparin-market